Mecanismos de la desnutrición en oncología pediátrica | Revista Española de Nutrición Humana y Dietética

Información del artículo

La desnutrición en el paciente oncológico tiene un origen multifactorial, que depende del paciente, el tipo de tumor, el tratamiento recibido y la aparición del síndrome de caquexia-anorexia cancerosa, que supone el grado máximo de desnutrición. La caquexia aparece como consecuencia de la interacción entre el tumor y el paciente; esta da lugar a la activación de distintos mediadores que producen cambios importantes en el metabolismo del paciente. En el niño, a diferencia del adulto, una mayor pérdida de peso no condiciona peor pronóstico, pero sí empeora su calidad de vida.

Palabras clave:

Desnutrición

Desnutrición calórico-proteica

Caquexia

Síndrome de caquexia-anorexia cancerosa

Mediadores

Oncología

Hospital Pediátrico

Malnutrition in cancer patients has a multifactorial origin. Will depend on the patient, tumour type, treatment received and the anorexia-cachexia syndrome onset, which is the maximum degree of malnutrition. Cachexia occurs as a consequence of the interaction between the tumour and the patient, leading to activation of different mediators that will produce important changes in the metabolism of the patient. Children with severe weight loss are not associated to lower survival, but their quality of life will be worse.

Keywords:

Malnutrition

Protein-energy malnutrition

Cachexia

Cancer anorexia-cachexia syndrome

Mediators

Oncology

Paediatric hospital

El Texto completo está disponible en PDF

Bibliografía

[1]

Argilés J.M..

Malnutrición y caquexia..

Malnutrición y caquexia., pp. 11-28

[2]

Mosby T, Day S, Challinor J, Hrenández A, García J, Velásquez S..

Nutritional issues in pediatric oncology: an international collaboration between the Central American Nurses Cooperative Group and U.S.-Based Dietary and Nursing Experts..

Pediatr Blood Cancer, 50 (2008), pp. 1298-1300

http://dx.doi.org/10.1002/pbc.21490 | Medline

[3]

Van Eys J..

Malnutrition in children with cancer: Incidence and consequence..

Cancer, 43 (1979), pp. 2030-2035

Medline

[4]

Coates TD, Rickard KA, Grosfeld J.L..

Nutritional support of children with neoplasic diseases..

Surg Clin North Am, 66 (1986), pp. 1197-1212

Medline

[5]

Kleiman R.E..

Pediatric nutrition handbook..

Pediatric nutrition handbook., (2004),

[6]

García Luna PP, Parejo Campos J, Pereira Cunill J.L..

Causas e impacto de la desnutrición y caquexia en el paciente oncológico..

Nutr Hosp, 21 (2006), pp. S10-S16

[7]

Argilés Huguet JM, Busquets Rius S, López-Soriano F.J..

Trastornos nutricionales: fisiopatología..

Trastornos nutricionales: fisiopatología., pp. 57-69

[8]

Kugman S, Dubowitz H..

Failure to thrive..

Am Fam Physician, 68 (2003), pp. 879-884

Medline

[9]

Bergman P, Graham J..

An approach to “failure to thrive”.

Aus Fam Physician, 34 (2005), pp. 725-729

[10]

Bosaeus I..

Nutritional support in multimodal therapy for cancer cachexia..

Support Care Cancer, 16 (2008), pp. 447-451

http://dx.doi.org/10.1007/s00520-007-0388-7 | Medline

[11]

Ladas EJ, Sacks N, Meacham L, Henry D, Enriquez L, Lowry G, et-al..

A multidisciplinary review on nutrition considerations in the pediatric oncology population: a perspective from Children's Oncology Group..

Nutr Clin Pract, 20 (2005), pp. 377-393

Medline

[12]

Huhman MB, August D.A..

Nutrition upport in surgical oncology..

Nutr Clin Pract, 24 (2009), pp. 520-526

http://dx.doi.org/10.1177/0884533609335375 | Medline

[13]

Kokal W.A..

The impact of antitumor therapy on nutrition..

Cancer, 55 (1985), pp. S273-S278

[14]

Barrera F..

Nutritional support in cancer patients..

JPEN, (2002), pp. S63-S70

[15]

Krishnaswamy K..

Drug metabolism and pharmacokinetics in malnourished children..

Clin Pharmacokinet, (1989), pp. S68-S88

[16]

Murry DJ, Riva L, Poplack D.G..

Impact of nutrition on pharmacokinetics of anti neoplastic agents..

Int J Cancer Suppl, 11 (1998), pp. 48-51

Medline

[17]

Anderson K.E..

Influences of diet and nutrition on clinical pharmacokinetics..

Clin Pharmacokinet, 14 (1998), pp. 325-346

http://dx.doi.org/10.2165/00003088-198814060-00002 | Medline

[18]

O’Gorman P, McMillan DC, McArdle C.S..

Impact of weight loss, apettite and the inflammatory response on quality of life I gastrointestinal cancer patients..

Nutr Cancer, 32 (1998), pp. 76-80

http://dx.doi.org/10.1080/01635589809514722 | Medline

[19]

Ladas EJ, Post-White J, Hawks R, Taromina K..

Evidence for symptom management in the child with cancer..

J Pediatr Hematol Oncol, 28 (2006), pp. 601-615

http://dx.doi.org/10.1097/01.mph.0000212989.26317.52 | Medline

[20]

Lai JS, Cella D, Peterman A, Barocas J, Goldman S..

Anorexia/cachexia-related quality of life for children with cancer..

Cancer, 104 (2005), pp. 1531-1539

http://dx.doi.org/10.1002/cncr.21315 | Medline

[21]

Argilés J.M..

Mediadores de la caquexia..

Mediadores de la caquexia., pp. 53-70

[22]

Esper DH, Harb W.A..

The cancer cachexia syndrome: a review of metabolic and clinical manifestations..

Nutr Clin Pract, 20 (2005), pp. 369-375

Medline

[23]

Argilés JM, Busquets S, López-Soriano FJ, Figueras M..

Fisiopatología de la caquexia neoplásica..

Nutr Hosp, (2006), pp. S4-S9

[24]

Argilés JM, Busquets S, Toledo M, López-Soriano F..

The role of cytokines in cancer cachexia..

Curr Opin Support Palliat Care, 3 (2009), pp. 263-268

http://dx.doi.org/10.1097/SPC.0b013e3283311d09 | Medline

[25]

Skipworth R.J.E, Stewart GD, Dejong C.H.C, Preston T, Fearon C.H..

Pathophysiology of cancer cachexia: Much more than host-tumour interaction?..

Clin Nutr, 26 (2007), pp. 667-676

http://dx.doi.org/10.1016/j.clnu.2007.03.011 | Medline

[26]

Argilés JM, Busquets S, López-Soriano J.L..

The pivotal role of cytokines in muscle wasting during cancer..

Int J Biochem Cell Biol, 37 (2005), pp. 1609-1619

http://dx.doi.org/10.1016/j.biocel.2005.03.007 | Medline

[27]

Ramos E.J.B, Suzuki S, Marks D, Inui A, Asakawa A, Meguid M.M..

Cancer anorexia-cachexia syndrome: cytokines and neuropeptides..

Curr Opin Clin Nutr Metab Care, 7 (2004), pp. 427-434

Medline

[28]

Argilés JM, Moore-Carrasco R, Fuster G, Busquets S, López-Soriano F.J..

Cancer cachexia: the molecular mechanism..

Int J Biochem Cell Biol, 35 (2003), pp. 405-409

Medline

[29]

Argilés JM, Busquets S, López-Soriano F.J..

Cytokines in the pathogenesis of cancer cachexia..

Curr Opin Clin Nutr Metab Care, 6 (2003), pp. 401-406

http://dx.doi.org/10.1097/01.mco.0000078983.18774.cc | Medline

[30]

Plata-Salamán C.R..

Central nervous system mechanism contributing to the cachexia-anorexia syndrome..

Nutrition, 16 (2000), pp. 1009-1012

Medline

[31]

Cardona D..

Tratamiento farmacológico de la anorexia-caquexia cancerosa..

Nutr Hosp, (2006), pp. S17-S26

[32]

Valassi E, Scacchi M, Cavagnini F..

Neuroendocrine control of food intake..

Nutr Metab Cardiovasc Dis, 18 (2008), pp. 158-168

http://dx.doi.org/10.1016/j.numecd.2007.06.004 | Medline

[33]

Fearon K.C.H..

Cancer cachexia: developing multimodal therapy for a multidimensional problem..

Eur J Cancer, 44 (2008), pp. 1124-1132

http://dx.doi.org/10.1016/j.ejca.2008.02.033 | Medline

[34]

Argilés J.M..

Mecanismos de la caquexia..

Mecanismos de la caquexia., pp. 29-52

[35]

Berg M, Fraker DL, Alexander H.R..

Charecterización of differentiation factor/leukaemia inhibitory factor effect on lipoproteinlipasa activity and mRNA in 3T3-L1 adipocytes..

Cytoquine, 6 (1994), pp. 425-432

[36]

Argilés JM, Busquets S, López-Soriano FJ, Figueras M..

Fisiología de la sarcopenia. Similitudes y diferencias con la caquexia neoplásica..

Nutr Hosp, (2006), pp. S38-S45

[37]

Planas M..

Relaciones entre el músculo y la nutrición clínica..

Nutr Hosp, (2006), pp. S1

[38]

Miján A, Martín E, Mateo B..

Caquexia cardiaca..

Nutr Hosp, (2006), pp. S84-S93

Síguenos:

Suscríbase a la newsletter